Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Science Board meeting

This article was originally published in The Tan Sheet

Executive Summary

FDA's Science Board will conduct a meeting on May 30 in Gaithersburg, Md., to discuss a subcommittee review of the National Center for Toxicological Research and Office of Regulatory Affairs, according to a May 1 Federal Register notice. The board will hear and discuss updates on a subcommittee review of the agency's science programs and infrastructure from Science Board meetings in June and December 2007, the notice says. The board will discuss keeping pace with technical and scientific evolutions in the fields of regulatory science. To request time for an oral presentation during the meeting, contact the Office of the Commissioner by May 15; to make written presentations to the board, information must be submitted by May 23...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel